Specifically, for the Forkhead-Ets families, we show that a joint upregulation of FOXO1-ETV6 in chronic lymphocytic leukemia (CLL) patients was associated with significantly higher time-to-treatment values. This evidence concerns the gene FOXO1 and B-cell chronic lymphocytic leukemia.